These cumulative health advantages may facilitate weight loss and promote general well-being
Petry ER, Cruzat VF, Heck TG, de Bittencourt PIH Int J Sport Nutr Exerc Metab
The Athlete IV helps restore lost fluids and improve nutrient absorption after exercise, which can help reduce feelings of soreness and exhaustion
MiR-410 regulates MET to influence the proliferation and invasion of glioma
In 2025, Novo Nordisks semaglutide awaits several first-time FDA decisions: Injectable GLP-1s 2025 Ozempic for T2DM and peripheral artery disease (PAD) 2H 2025 Wegovy for heart failure with preserved ejection fraction (HFpEF) and obesity Oral GLP-1s October 2025 new indication for oral Rybelsus for secondary CV risk reduction 4Q 2025 the first oral GLP-1 ( oral formulation of Wegovy 25 mg ) for weight loss and weight loss plus secondary CV risk reduction Given the considerable continued growth expected in the GLP-1 pipeline, Prime Therapeutics (Prime) talented team of clinical experts actively monitors this emerging landscape
5.3.3 Ferroptosis in coronary microvascular dysfunction Coronary microvascular dysfunction, a distinct pathological entity within the spectrum of coronary heart disease, involves significant ferroptotic endothelial cell death
